Tandem Diabetes Care
TNDM
16.11
+0.44
+2.78%
Tandem Diabetes Care
US · TNDM
#3179 by market cap
16.11
+0.44
+2.78%
Live - 5344 symbols - heartbeat 45s ago
· 2026-10-09 19:30
Analyst consensus 12 analysts
Buy
Avg price target
28.18 +74.9%
Price target rangecurrent 16.11
Low18.00
Avg28.18
High50.00
Buy 58%
Hold 42%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-07 | Barclays | -- | HOLD | 18.00 |
| 2026-10-01 | Citi | -- | HOLD | 20.00 |
| 2026-10-01 | RBC Capital | -- | BUY | 26.00 |
| 2026-09-30 | Citi | -- | HOLD | 20.00 |
| 2026-09-28 | Lake Street | -- | BUY | 50.00 |
| 2026-09-24 | Truist Financial | -- | BUY | 28.00 |
| 2026-08-21 | William Blair | -- | BUY | -- |
| 2026-08-14 | Citi | -- | HOLD | 24.00 |
| 2026-08-11 | CCORF | -- | BUY | 40.00 |
| 2026-08-07 | CCORF | -- | BUY | 40.00 |
| 2026-08-07 | Piper Sandler | -- | BUY | 33.00 |
| 2026-08-07 | BofA Securities | -- | HOLD | 25.00 |
| 2026-08-07 | Truist Financial | -- | BUY | 31.00 |
| 2026-08-07 | Stifel | -- | HOLD | 22.00 |
| 2026-08-07 | Citi | -- | HOLD | 21.00 |
| 2026-08-07 | Lake Street | -- | BUY | 50.00 |
| 2026-08-06 | TD Cowen | -- | BUY | 28.00 |
| 2026-08-06 | RBC Capital | -- | BUY | 26.00 |
| 2026-07-15 | Mizuho Securities | -- | HOLD | 20.00 |
| 2026-07-08 | Citi | -- | HOLD | 17.00 |
| 2026-06-23 | Deutsche Bank | -- | HOLD | 15.50 |
| 2026-06-08 | BofA Securities | -- | HOLD | 25.00 |
| 2026-06-01 | Wells Fargo | -- | BUY | 27.00 |
| 2026-05-31 | Wells Fargo | -- | BUY | 27.00 |
| 2026-05-29 | Citi | -- | HOLD | 17.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
5 1
■ Upgrades■ Downgrades
- 5 upgrades vs 1 downgrade among tracked analyst rating changes.
- The single most recent change was actually a downgrade (Barclays moved from Buy to Hold on 2026-10-07), though the broader window skews toward upgrades.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-10-07 | Barclays | BUY → HOLD | 18.00 |
| 2026-05-31 | Wells Fargo | HOLD → BUY | 27.00 |
| 2026-03-18 | Truist Financial | HOLD → BUY | 35.00 |
| 2026-03-17 | Piper Sandler | HOLD → BUY | 33.00 |
| 2026-02-23 | Lake Street | HOLD → BUY | 50.00 |
| 2025-12-16 | Baird | HOLD → BUY | 30.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-06 | After close | ±16.70% | +19.11% (beat) |
| 2026/Q1 | 2026-05-07 | After close | ±19.15% | -16.19% (in line) |
| 2025/Q4 | 2026-02-19 | After close | ±17.98% | +32.67% (beat) |
| 2025/Q3 | 2025-11-06 | After close | ±21.72% | +21.98% (beat) |
| 2025/Q2 | 2025-08-06 | After close | ±19.39% | -19.94% (beat) |
| 2025/Q1 | 2025-04-30 | After close | ±19.63% | +18.58% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±16.72% | -35.25% (beat) |
| 2024/Q3 | 2024-11-06 | After close | ±20.01% | -2.69% (in line) |
| 2024/Q2 | 2024-08-01 | After close | ±21.07% | +18.35% (in line) |
| 2024/Q1 | 2024-05-02 | After close | ±16.47% | +22.32% (beat) |
| 2023/Q4 | 2024-02-21 | After close | ±20.84% | +10.86% (in line) |
| 2023/Q3 | 2023-11-01 | After close | ±20.45% | -14.37% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Tandem Diabetes Care discussion 0 comments